[1]
Tanimoto Duque, F.A. et al. 2022. Evaluation of pediatric hydroxyurea prescriptions for patients with sickle cell disease. O Mundo da Saúde. 46, (Nov. 2022), 369–379. DOI:https://doi.org/10.15343/0104-7809.202246369379P.